Cell tracking in cardiac repair: What to image and how to image

European Radiology

Volumn 22, Issue 1, 2012, Pages 189-204

  Ruggiero, Alessandro ^a   Thorek, Daniel L J ^b   Guenoun, Jamal ^a   Krestin, Gabriel P ^a   Bernsen, Monique R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell tracking; Heart failure; Molecular imaging; Myocardial infarction; Stem cells

Indexed keywords

GADOLINIUM; MANGANESE CHLORIDE; RADIOISOTOPE; SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGENESIS; BIOLUMINESCENCE; CARDIOMYOGENESIS; CELL LABELING; CELL REGENERATION; CELL TRACKING; ENGRAFTMENT; FLUORESCENCE IMAGING; FLUORINE NUCLEAR MAGNETIC RESONANCE; HEART; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION;

CELL TRACKING; FEMALE; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; INDUCED PLURIPOTENT STEM CELLS; MALE; MOLECULAR IMAGING; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84857062905     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2190-7     Document Type: Review

References (116)

1. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705. doi:10.1038/35070587 (Pubitemid 32290358)
2. Strauer BE, Brehm M, Zeus T et al (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918 (Pubitemid 35176294)
3. Abdel-Latif A, Bolli R, Tleyjeh IM et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989-997. doi:10.1001/archinte.167.10.989 (Pubitemid 46835786)
4. Lipinski MJ, Biondi-Zoccai GG, Abbate A et al (2007) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50:1761-1767. doi:10.1016/j.jacc. 2007.07.041 (Pubitemid 47600592)
5. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM (2008) Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29:1807-1818. doi:10.1093/eurheartj/ehn220
6. Korf-Klingebiel M, Kempf T, Sauer T et al (2008) Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 29:2851-2858. doi:10.1093/eurheartj/ehn456
7. Taylor DA, Atkins BZ, Hungspreugs P et al (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-933 (Pubitemid 28364032)
8. Menasche P, Alfieri O, Janssens S et al (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200. doi:10.1161/CIRCULATIONAHA.107.734103 (Pubitemid 351552018)
9. Yoon YS, Wecker A, Heyd L et al (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115:326-338. doi:10.1172/JCI22326 (Pubitemid 40385474)
10. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673. doi:10.1038/nature02460 (Pubitemid 38524811)
11. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668. doi:10.1038/nature02446 (Pubitemid 38524810)
12. Ferrari G, Cusella-De Angelis G, Coletta M et al (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530 (Pubitemid 28217075)
13. Quevedo HC, Hatzistergos KE, Oskouei BN et al (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 106:14022-14027. doi:10.1073/pnas.0903201106
14. Polascik TJ, Manyak MJ, Haseman MK et al (1999) Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer 85:1586-1592. doi:10.1002/(SICI)1097-0142(19990401) 85:7<1586::AID- CNCR21>3.0.CO;2-F (Pubitemid 29152832)
15. Wang L, Deng J, Tian Wet al (2009) Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol 297:H1020-H1031. doi:10.1152/ajpheart.01082.2008
16. Schachinger V, Assmus B, Britten MB et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCAREAMI Trial. J Am Coll Cardiol 44:1690-1699. doi:10.1016/j. jacc.2004.08.014 (Pubitemid 39369805)
17. Beltrami AP, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776 (Pubitemid 37186770)
18. Dawn B, Stein AB, Urbanek K et al (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102:3766-3771. doi:10.1073/pnas.0405957102 (Pubitemid 40354686)
19. Laflamme MA, Chen KY, Naumova AV et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024. doi:10.1038/nbt1327 (Pubitemid 47517637)
20. Li Z, Wu JC, Sheikh AY et al (2007) Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116(Suppl):I46-I54. doi:10.1161/CIRCULATIONAHA.106.680561 (Pubitemid 47480769)
21. Swijnenburg RJ, Schrepfer S, Cao F et al (2008) In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev 17:1023-1029. doi:10.1089/scd.2008.0091
22. Nussbaum J, Minami E, Laflamme MA et al (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21:1345-1357. doi:10.1096/fj.06-6769com (Pubitemid 46684837)
23. Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920. doi:10.1126/science.1151526
24. Zwi L, Caspi O, Arbel G et al (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120:1513-1523. doi:10.1161/CIRCULATIONAHA.109.868885
25. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416. doi:10.1161/ CIRCULATIONAHA.109.865154
26. Kocher AA, Schuster MD, Szabolcs MJ et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436. doi:10.1038/86498 (Pubitemid 32298545)
27. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S (2009) The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 54:1407-1424. doi:10.1016/j.jacc.2009.04.094
28. Chen IY, Wu JC Cardiovascular molecular imaging: focus on clinical translation. Circulation 123:425-443. doi: 10.1161/CIRCULATIONAHA.109.916338
29. Kiessling F (2008) Noninvasive cell tracking. Handb Exp Pharmacol (185 Pt 2):305-321. doi: 10.1007/978-3-540-77496-9-13
30. Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 218:27-38
31. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. NEngl JMed 348:2491-2499. doi:10.1056/NEJMoa022749 (Pubitemid 36706536)
32. Thorek DLJ, Tsourkas A (2008) Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29:3583-3590
33. Bernsen MR, Moelker AD, Wielopolski PA, van Tiel ST, Krestin GP Labelling of mammalian cells for visualisation by MRI. Eur Radiol 20:255-274. doi:10.1007/s00330-009-1540-1
34. Arbab AS, Pandit SD, Anderson SA et al (2006) Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24:671-678. doi:10.1634/stemcells.2005-0017
35. Hsiao JK, Chu HH, Wang YH et al (2008) Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed 21:820-829. doi:10.1002/nbm.1260
36. Delcroix GJ, JacquartM, Lemaire L et al (2009)Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res 1255:18-31. doi:10.1016/j. brainres.2008.12.013
37. Farrell E, Wielopolski P, Pavljasevic P et al (2009) Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour. Osteoarthr Cartil 17:961-967
38. Magnitsky S, Walton RM, Wolfe JH, Poptani H (2008) Magnetic resonance imaging detects differences in migration between primary and immortalized neural stem cells. Acad Radiol 15:1269-1281. doi:10.1016/j.acra.2008.05.003
39. Schafer R, Kehlbach R, Muller M et al (2009) Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 11:68-78
40. Yang J-X, Tang W-L, Wang X-X (2010) Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy 12:251-259
41. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JWM (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17:513-517 (Pubitemid 39549429)
42. Chen I, Greve J, Gheysens O et al (2009) Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol 11:178-187
43. Amsalem Y, Mardor Y, Feinberg MS, et al (2007) Iron-Oxide Labeling and Outcome of Transplanted Mesenchymal Stem Cells in the Infarcted Myocardium. Circulation 116(suppl):I-38-45. doi: 10.1161/circulationaha.106.680231 (Pubitemid 47480768)
44. Winter EM, Hogers B, van der Graaf LM, Gittenberger-de Groot AC, Poelmann RE, van der Weerd L Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn Reson Med 63:817-821. doi: 10.1002/mrm.22094
45. Terrovitis J, Stuber M, Youssef A et al (2008) Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117:1555-1562. doi:10.1161/CIRCULATIONAHA.107.732073 (Pubitemid 351444664)
46. van den Bos EJ, Baks T, Moelker AD et al (2006) Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts possible interference with iron oxide-labelled cell tracking? Eur Heart J 27:1620-1626. doi:10.1093/eurheartj/ehl059 (Pubitemid 43954924)
47. Brekke C, Morgan SC, Lowe AS et al (2007) The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed 20:77-89. doi:10.1002/nbm.1077 (Pubitemid 46470930)
48. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E (2009) Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res 42:822-831. doi:10.1021/ar800192p
49. Gianolio E, Arena F, Strijkers GJ, Nicolay K, Hogset A, Aime S Photochemical activation of endosomal escape of MRI-Gd-agents in tumor cells. Magn Reson Med. doi: 10.1002/mrm.22586
50. Bulte JW (2009) In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 193:314-325. doi:10.2214/AJR.09.3107
51. Yamada M, Gurney PT, Chung J et al (2009) Manganeseguided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability. Magn Reson Med 62:1047-1054
52. Gilad AA, Walczak P, McMahon MT et al (2008) MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med 60:1-7. doi:10.1002/mrm.21622 (Pubitemid 351956602)
53. Tran LA, Krishnamurthy R, Muthupillai R, et al. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials 31:9482-9491. doi: 10.1016/j.biomaterials.2010.08.034
54. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJ (2010) (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol 28:363-370. doi:10.1016/j.tibtech.2010.04.002
55. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET (2007) Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 58:725-734 (Pubitemid 47556877)
56. Partlow KC, Chen J, Brant JA et al (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21:1647-1654. doi:10.1096/fj.06-6505com (Pubitemid 46855610)
57. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545-580. doi:10.1101/gad.1047403 (Pubitemid 36307540)
58. Aicher A, Brenner W, Zuhayra M et al (2003) Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134-2139. doi:10.1161/01.CIR.0000062649.63838.C9 (Pubitemid 36532196)
59. Barbash IM, Chouraqui P, Baron J et al (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863-868. doi:10.1161/01. CIR.0000084828.50310.6A (Pubitemid 37022130)
60. Hou D, Youssef EA, Brinton TJ et al (2005) Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112(9 Suppl):I150-I156. doi:10.1161/CIRCULATIONAHA.104.526749 (Pubitemid 41266667)
61. Schachinger V, Aicher A, Dobert N et al (2008) Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118:1425-1432. doi:10.1161/CIRCULATIONAHA.108.777102
62. Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL (2003) 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 24:1149-1154. doi:10.1097/01. mnm.0000101606.64255.03 (Pubitemid 39625401)
63. Brenner W, Aicher A, Eckey T et al (2004) 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512-518 (Pubitemid 47618629)
64. Penicka M, Lang O, Widimsky P et al (2007) One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart 93:837-841. doi:10.1136/hrt.2006.091934 (Pubitemid 46998985)
65. Blackwood KJ, Lewden B, Wells RG et al (2009) In vivo SPECT quantification of transplanted cell survival after engraftment using (111)In-tropolone in infarcted canine myocardium. J Nucl Med 50:927-935. doi:10.2967/jnumed.108.058966
66. Mitchell AJ, Sabondjian E, Sykes J, et al. Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. J Nucl Med 51:413-417. doi: 10.2967/jnumed.109.069732
67. Nowak B, Weber C, Schober A et al (2007) Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells. Eur J Nucl Med Mol Imaging 34:715-721. doi:10.1007/s00259-006-0275-3 (Pubitemid 46669358)
68. Yoon JK, Park BN, Shim WY, Shin JY, Lee G, Ahn YH In vivo tracking of 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model. Nucl Med Biol 37:381-388 doi: 1016/j.nucmedbio.2009.12.001
69. Gholamrezanezhad A, Mirpour S, Ardekani JM et al (2009) Cytotoxicity of 111In-oxine on mesenchymal stem cells: a timedependent adverse effect. Nucl Med Commun 30:210-216. doi:10.1097/MNM.0b013e328318b328
70. Rahmim A, Zaidi H (2008) PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun 29:193-207. doi:10.1097/MNM.0b013e3282f3a515 (Pubitemid 351499295)
71. Doyle B, Kemp BJ, Chareonthaitawee P et al (2007) Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 48:1708-1714. doi:10.2967/jnumed.107.042838 (Pubitemid 47572719)
72. Hofmann M, Wollert KC, Meyer GP et al (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202. doi:10.1161/01. CIR.0000163546.27639.AA (Pubitemid 40632435)
73. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS (2006) Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 47:1295-1301
74. Adonai N, Nguyen KN, Walsh J et al (2002) Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 99:3030-3035. doi:10.1073/pnas.052709599 (Pubitemid 34240580)
75. Serganova I, Mayer-Kukuck P, Huang R, Blasberg R (2008) Molecular imaging: reporter gene imaging. Handb Exp Pharmacol (185 Pt 2):167-223. doi: 10.1007/978-3-540-77496-9-8
76. Kammili RK, Taylor DG, Xia J, et al. Generation of novel reporter stem cells and their application for non-invasive molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev. doi: 10.1089/scd.2009.0308
77. Ruggiero A, Brader P, Serganova I, et al. Different strategies for reducing intestinal background radioactivity associated with imaging HSV1-tk expression using established radionucleoside probes. Mol Imaging 9:47-58.
78. Wu JC, Chen IY, Sundaresan G et al (2003) Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108:1302-1305. doi:10.1161/01.CIR. 0000091252.20010.6E (Pubitemid 37174406)
79. Cao F, Lin S, Xie X et al (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005-1014. doi:10.1161/CIRCULATIO NAHA.105.588954 (Pubitemid 43879476)
80. Berger C, Flowers ME, Warren EH, Riddell SR (2006) Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. Blood 107:2294-2302. doi:10.1182/blood-2005- 08-3503 (Pubitemid 43345547)
81. Ponomarev V, Doubrovin M, Shavrin A et al (2007) A humanderived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. J Nucl Med 48:819-826. doi:10.2967/jnumed.106.036962 (Pubitemid 47604984)
82. Terrovitis J, Kwok KF, Lautamaki R et al (2008) Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 52:1652-1660. doi:10.1016/j.jacc.2008.06.051
83. Gray SJ, Samulski RJ (2008) Optimizing gene delivery vectors for the treatment of heart disease. Expert Opin Biol Ther 8:911-922. doi:10.1517/14712598.8.7.911 (Pubitemid 352007003)
84. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA (2003) High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21:111-117. doi:10.1634/stemcells.21-1-111 (Pubitemid 36120372)
85. Toelen J, Deroose CM, Gijsbers R et al (2007) Fetal gene transfer with lentiviral vectors: long-term in vivo follow-up evaluation in a rat model. Am J Obstet Gynecol 196(352):e351-e356. doi:10.1016/j.ajog.2007.01.038 (Pubitemid 46509618)
86. Krishnan M, Park JM, Cao F et al (2006) Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J 20:106-108. doi:10.1096/fj.05-4551fje (Pubitemid 43100482)
87. Mikkers H, Berns A (2003) Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res 88:53-99 (Pubitemid 36343279)
88. Zurkiya O, Chan AW, Hu X (2008) MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 59:1225-1231. doi:10.1002/mrm.21606 (Pubitemid 351813249)
89. Gilad AA, McMahon MT, Walczak P et al (2007) Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 25:217-219. doi:10.1038/nbt1277 (Pubitemid 46227121)
90. Naumova AV, Reinecke H, Yarnykh V, Deem J, Yuan C, Charles EM Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging 9:201-210.
91. Wang J, Zhang S, Rabinovich B, et al. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106:1904-1911. doi: 10.1161/CIRCRESAHA.110.221762
92. Ly HQ, Hoshino K, Pomerantseva I et al (2009) In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. Eur Heart J 30:2861-2868. doi:10.1093/eurheartj/ehp322
93. Muller-Borer BJ, Collins MC, Gunst PR, Cascio WE, Kypson AP (2007) Quantum dot labeling of mesenchymal stem cells. J Nanobiotechnology 5:9. doi:10.1186/1477-3155-5-9
94. Lin S, Xie X, Patel MR et al (2007) Quantum dot imaging for embryonic stem cells. BMC Biotechnol 7:67. doi:10.1186/1472-6750-7-67
95. Rosen AB, Kelly DJ, Schuldt AJ et al (2007) Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25:2128-2138. doi:10.1634/stemcells.2006-0722 (Pubitemid 47258192)
96. Hardman R (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165-172 (Pubitemid 43193634)
97. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D (2005) Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377-385. doi:10.1007/s00109-004-0629-x (Pubitemid 41201802)
98. Qiao H, Zhang H, Zheng Y et al (2009) Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250:821-829. doi:10.1148/radiol.2503080205
99. Higuchi T, Anton M, Dumler K et al (2009) Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med 50:1088-1094. doi:10.2967/jnumed.108.060665
100. Ray P, De A, Min JJ, Tsien RY, Gambhir SS (2004) Imaging trifusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330 (Pubitemid 38235600)
101. Schachinger V, Erbs S, Elsasser A et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221. doi:10.1056/NEJMoa060186 (Pubitemid 44427445)
102. Schachinger V, Erbs S, Elsasser A et al (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acutemyocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775-2783. doi:10.1093/eurheartj/ehl388 (Pubitemid 44871463)
103. Beitnes JO, Hopp E, Lunde K et al (2009) Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 95:1983-1989. doi:10.1136/hrt.2009.178913
104. Lunde K, Solheim S, Aakhus S et al (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199-1209. doi:10.1056/NEJMoa055706 (Pubitemid 44427444)
105. Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148. doi:10.1016/S0140-6736(04)16626-9 (Pubitemid 38891685)
106. Meyer GP, Wollert KC, Lotz J et al (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year followup from the randomized-controlled BOOST trial. Eur Heart J 30:2978-2984. doi:10.1093/eurheartj/ehp374
107. Janssens S, Dubois C, Bogaert J et al (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367:113-121. doi:10.1016/S0140-6736(05) 67861-0 (Pubitemid 43077127)
108. Meluzin J, Janousek S, Mayer J et al (2008) Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int J Cardiol 128:185-192. doi:10.1016/j.ijcard.2007.04.098
109. Chen SL, Fang WW, Ye F et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bonemarrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95. doi:10.1016/j.amjcard.2004.03.034 (Pubitemid 38813459)
110. Dill T, Schachinger V, Rolf A et al (2009) Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIRAMI) cardiac magnetic resonance imaging substudy. Am Heart J 157:541-547. doi:10.1016/j.ahj.2008.11.011
111. Kraitchman DL, Heldman AW, Atalar E et al (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290-2293. doi:10.1161/CIR.0000070931.62772.4E (Pubitemid 36578497)
112. Amado LC, Saliaris AP, Schuleri KH et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102:11474-11479. doi:10.1073/pnas.0504388102 (Pubitemid 41153844)
113. Stuckey DJ, Carr CA, Martin-Rendon E et al (2006) Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells 24:1968-1975. doi:10.1634/stemcells.2006-0074 (Pubitemid 44474173)
114. Ebert SN, Taylor DG, Nguyen HL et al (2007) Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 25:2936-2944. doi:10.1634/stemcells.2007-0216 (Pubitemid 350127879)
115. Chapon C, Jackson JS, Aboagye EO, Herlihy AH, Jones WA, Bhakoo KK (2009) An in vivo multimodal imaging study usingMRI and PETof stem cell transplantation after myocardial infarction in rats. Mol Imaging Biol 11:31-38. doi:10.1007/s11307-008-0174-z
116. Li Z, Lee A, Huang M et al (2009) Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol 53:1229-1240. doi:10.1016/j.jacc.2008.12.036